- Alogliptin in patients with type 2 diabetes on metformin and sulfonylurea therapies in the EXAMINE Trial
- Overall survival benefit in patients with rituximab-refractory indolent non-hodgkin lymphoma who received obinutuzumab plus bendamustine induction and obinutuzumab maintenance in the GADOLIN study
- Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: A systematic review and meta-analysis
- Trends in medical use of opioids in the U.S., 2006–2016
- Usefulness of high dose oral flecainide for termination of recent onset atrial fibrillation in children
- Randomized phase II trial of carboplatin-paclitaxel vs carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2/neu
- Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer
- Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: Patient-reported outcomes
- Rate of patients at elevated risk of opioid overdose visiting the Emergency Department
- Proteomic analysis of plasma from rheumatoid arthritis patients with mild cognitive impairment
- Efficacy and safety of first-line avelumab treatment in patients with stage IV metastatic Merkel cell carcinoma: A preplanned interim analysis of a clinical trial
- Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: A clinical trial
- Myoepithelioma of soft tissues: A single institution retrospective case series
- Off-label use of tacrolimus in children with Henoch-Schonlein purpura nephritis: A pilot study
- Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: Is there a need?
Feed Sources
